Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Pietschmann

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Clinical and Experimental Medicine|October 15, 2018
Myostatin and other musculoskeletal markers in lung transplant recipientsKatharina Kerschan-Schindl, Gerold Ebenbichler, Wolfgang Gruther, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 18, 2021
Longitudinal Changes of Circulating miRNAs During Bisphosphonate and Teriparatide Treatment in an Animal Model of Postmenopausal OsteoporosisMoritz Weigl, Roland Kocijan, James Ferguson, et al.
Wiener Klinische Wochenschrift|September 2, 2018
Rheumatoid arthritis in remission : Decreased myostatin and increased serum levels of periostinKatharina Kerschan-Schindl, Gerold Ebenbichler, Ursula Föeger-Samwald, et al.
Bone|November 5, 2019
MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosisRoland Kocijan, Moritz Weigl, Susanna Skalicky, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 9, 2013
Intravenous treatment with ibandronate normalizes bone matrix mineralization and reduces cortical porosity after two years in male osteoporosis: a paired biopsy studyBarbara M Misof, Janina M Patsch, Paul Roschger, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 28, 2007
Unexpected low incidence of vertebral fractures in heart transplant recipients: analysis of bone turnoverKatharina Kerschan-Schindl, Margot Ruzicka, Stephane Mahr, et al.
Metallomics : Integrated Biometal Science|February 15, 2017
Effect of vanadium on calcium homeostasis, osteopontin mRNA expression, and bone microarchitecture in diabetic ratsCristina Sanchez-Gonzalez, Laura Moreno, Carlos Lopez-Chaves, et al.
Journal of Nephrology|May 21, 2004
Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysisHarald Kotzmann, Michaela Riedl, Peter Pietschmann, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|June 28, 2015
Atypical Femoral Fractures-Ongoing and History of Bone-Specific Therapy, Concomitant Diseases, Medications, and SurvivalChristian Muschitz, Heinrich W Thaler, Hans Peter Dimai, et al.
Bone|June 1, 2015
Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiationSylvia Weilner, Susanna Skalicky, Benjamin Salzer, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Clinical and Experimental Medicine|October 15, 2018
Myostatin and other musculoskeletal markers in lung transplant recipientsKatharina Kerschan-Schindl, Gerold Ebenbichler, Wolfgang Gruther, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 18, 2021
Longitudinal Changes of Circulating miRNAs During Bisphosphonate and Teriparatide Treatment in an Animal Model of Postmenopausal OsteoporosisMoritz Weigl, Roland Kocijan, James Ferguson, et al.
Wiener Klinische Wochenschrift|September 2, 2018
Rheumatoid arthritis in remission : Decreased myostatin and increased serum levels of periostinKatharina Kerschan-Schindl, Gerold Ebenbichler, Ursula Föeger-Samwald, et al.
Bone|November 5, 2019
MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosisRoland Kocijan, Moritz Weigl, Susanna Skalicky, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 9, 2013
Intravenous treatment with ibandronate normalizes bone matrix mineralization and reduces cortical porosity after two years in male osteoporosis: a paired biopsy studyBarbara M Misof, Janina M Patsch, Paul Roschger, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 28, 2007
Unexpected low incidence of vertebral fractures in heart transplant recipients: analysis of bone turnoverKatharina Kerschan-Schindl, Margot Ruzicka, Stephane Mahr, et al.
Metallomics : Integrated Biometal Science|February 15, 2017
Effect of vanadium on calcium homeostasis, osteopontin mRNA expression, and bone microarchitecture in diabetic ratsCristina Sanchez-Gonzalez, Laura Moreno, Carlos Lopez-Chaves, et al.
Journal of Nephrology|May 21, 2004
Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysisHarald Kotzmann, Michaela Riedl, Peter Pietschmann, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|June 28, 2015
Atypical Femoral Fractures-Ongoing and History of Bone-Specific Therapy, Concomitant Diseases, Medications, and SurvivalChristian Muschitz, Heinrich W Thaler, Hans Peter Dimai, et al.
Bone|June 1, 2015
Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiationSylvia Weilner, Susanna Skalicky, Benjamin Salzer, et al.
Pageof 16